• Mashup Score: 1
    Digitally Decentralized by Design - 1 year(s) ago

    Through a partnership with software developer Medable, Syneos Health aims to decentralize clinical trials and make them more accessible and personalized.

    Source: The Medicine Maker
    Categories: Future of Medicine, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of medableinc
      medableinc

      Through partnership, Medable & @SyneosHealth will decentralize clinical trials to make them more accessible & personalized, because patients deserve better. Learn more: https://t.co/DtuL65zU7b ________ #clinicaltrials #clinicalresearch #decentralizedtrials #healthcare

  • Mashup Score: 1
    HyperReality Check - 2 year(s) ago

    Mike Rea of IDEA Pharma speaks frankly on the mud fights, echo chambers, and risks at play in the virtual forums of social media in 2021.

    Source: The Medicine Maker
    Categories: Future of Medicine, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of JohnNosta
      JohnNosta

      RT @ideapharma: From my interview with @AngusLikesWords in @medicine_maker https://t.co/S5ctm4kSDT https://t.co/1zIlj3piKO

  • Mashup Score: 0
    The Human Yin to the Clinical Yang - 3 year(s) ago

    How can advocacy groups help improve the clinical trials landscape?

    Source: The Medicine Maker
    Categories: Future of Medicine, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of medableinc
      medableinc

      Creating diversity in medicine is the fundamental goal of our Patient Advisory Council members. Discover from Allison Kalloo why patient advocacy in clinical trial design should, & will, become the norm, rather than the exception. Read here: https://t.co/hRSasUFF0Z #diversity https://t.co/SlPCwqYBbt

  • Mashup Score: 0
    Clinical Trials and Tribulations - 3 year(s) ago

    When it comes to clinical trials, is pharma making the best use of digital technologies?

    Source: The Medicine Maker
    Categories: Future of Medicine, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of medableinc
      medableinc

      Removing patient burdens, such as the 42 mile drive the average patient takes for clinical trial appointments, is a crucial benefit of utilising digital technologies in research. Learn more from @paragvaish, here: https://t.co/cCrKW0JD4t #decentralizedtrials #clinicaltrials https://t.co/O5IFFkwHMl

  • Mashup Score: 0
    A Living Elixir? - 4 year(s) ago

    Microorganisms isolated from the human gut have the potential to treat disease without much risk of adverse effects. Duncan Peyton explains why he’s so excited about the fourth class of therapeutics: live biotherapeutics.

    Source: The Medicine Maker
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mitcharj
      mitcharj

      The Fourth Therapeutic Class: Live Biotherapeutics https://t.co/rHGXqElMRW @4dpharmaplc $DDDD